CE EVENING SESSIONS
DIFFERENTIATING NORMAL FROM ABNORMAL ON A FUNDIC EXAMINATION Renee Carter, DVM, DACVO 8:00 PM - 8:50 PM | Ballroom A Approach to the evaluation of the canine and feline fundus will be presented along with examples of normal variation. Tips to distinguish these normal variations from pathological lesions will be reviewed. FEVER OF UNKNOWN ORIGIN IN DOGS AND CATS Kenneth Harkin, DVM, DACVIM (SAIM) 6:00 PM - 6:50 PM | Ballroom C Fever does not always present with an obvious pathway for immediate diagnosis and treatment. This lecture will focus on a practical approach to dogs and cats with fever with an emphasis on diagnostic and therapeutic algorithms to help the veterinarian identify the etiology. LEPTOSPIROSIS: A LOOK AT THE CLINICAL DISEASE IN DOGS AND OTHER SPECIES Kenneth Harkin, DVM, DACVIM (SAIM) 7:00 PM - 7:50 PM | Ballroom C The focus of this lecture on leptospirosis, one of the most important worldwide zoonotic diseases, will be historical background, reservoirs and transmission, risk factors and clinical manifestations of the disease. The primary focus will be leptospirosis in dogs, but disease in cats, humans, and other species will be introduced. LEPTOSPIROSIS: SO MUCH MORE TO KNOW ABOUT THE DIAGNOSIS, THERAPY AND MONITORING OF LEPTOSPIROSIS IN DOGS Kenneth Harkin, DVM, DACVIM (SAIM) 8:00 PM - 8:50 PM | Ballroom C The focus of this lecture will be to make sense of the various diagnostic tests available and helping the veterinarian interpret the results and how recent findings may change how the veterinarian approaches the therapy and monitoring of the dog with leptospirosis. CANINE TRACHEAL COLLAPSE Tracheal collapse is a common obstructive airway disorder in toy and small-breed dogs presenting with a constellation of respiratory signs dependent on severity of collapse. This lecture will review the diagnostic and therapeutic work up, with an emphasis on identification of co-morbid conditions that are likely to influence outcome. Treatment strategies including addressing such conditions and medical and interventional (ie stents) therapies will be discussed. THORACIC RADIOGRAPHIC INTERPRETATION: AN INTERNIST’S PERSPECTIVE Interpretation of thoracic radiographic images is often key to localizing respiratory disease and narrowing a list of differential diagnoses. In a step-wise approach, this lecture will use a series of cases to illustrate how information of thoracic radiography can be used to guide case management in dogs and cats. PHARMACOLOGIC MANAGEMENT OF RESPIRATORY DISEASE Carol Reinero, DVM, PhD, DACVIM 7:00 PM - 7:50 PM | Room 200 Carol Reinero, DVM, PhD, DACVIM 8:00 PM - 8:50 PM | Room 200 A variety of medications are available to help treat respiratory disorders including obstructive airway disease, parasitic respiratory disease, inflammatory airway disease, pneumonia, and pulmonary hypertension. Using clinical case examples, in this lecture we will review the indications, contraindications and limitations of common (and sometimes not so common) drugs used to treat respiratory disorders in dogs and cats. SATURDAY, SEPTEMBER 24 CANINE BRUCELLOSIS – A RISING TIDE Joni Freshman, DVM, MS, DACVIM (SAIM), CVA, CVCP 6:00 PM - 6:50 PM | Room 200 This incurable (in dogs), zoonotic disease is spreading, not just across the world, but increasingly in the USA with affected dogs not always those you suspect (spoiler alert: young puppies and spayed and neutered dogs are NOT exempt). Learn all you need Carol Reinero, DVM, PhD, DACVIM 6:00 PM - 6:50 PM | Room 200
horses with perspectives on how this data can inform safe and effective applications in specific disease conditions. Sponsor: THE ENDOCANNABINOID SYSTEM OF ANIMALS: THE TARGET FOR CANNABIS Robert Silver, DVM, MS, CVA 7:00 PM - 7:50 PM | Room 204 A The Endocannabinoid System (ECS) consists of membrane receptors, endogenous ligands and biosynthetic and degradative enzymes. All mammals have been found to have an ECS as well as many invertebrates. It was recently “discovered” in the mid 1990’s following the determination of the structure of THC. Subsequent research has determined the widespread influence of the ECS on multiple systems within the body, including the nervous system and immune systems, as well as in every other system in the body. Understanding the functions of the ECS will lead to more effective applications for veterinary cannabis applications. The discovery of the Endocannabinoidome (ECB) of which the ECS is a vital part has been an important factor in drug development pathways by Pharma. The ECB contains the ECS as well as multiple metabolites and congeners, all of which are directed toward establishing and maintaining homeostasis in nearly every system in the body. The ECS and ECB are both targets for the many molecules derived from Cannabis sativa L. Learning Objectives; • Understand the components of the Endocannabinoid System, including multiple membrane receptors, transport molecules and degradative and biosynthetic enzymes; • Learn how the many active molecules derived from cannabis can influence these three components of the ECS; • Gain knowledge of how the ECS influences disease expression, and what clinical strategies can help to improve clinical outcomes for conditions such as osteoarthritis, neurodegenerative disorders, behavioral issues and neoplasia in veterinary species as well as laboratory animals and humans. Sponsor: PRACTICAL THERAPEUTICS: ADMINISTRATION AND DOSING STRATEGIES, PRODUCT SELECTION GUIDANCE AND RATIO PRODUCTS Robert Silver, DVM, MS, CVA 8:00 PM - 8:50 PM | Room 204 A Our understanding of the therapeutic potential of cannabis for veterinary species is increasing as veterinary-specific studies are being more frequently published. Nonetheless, there is a lack of experience amongst veterinarians in establishing safe and effective dosing and administration strategies for their patients. In the absence of Phase One tiered dosing studies, fixed doses used in studies have been suggested. These doses may be impractically excessive for prolonged clinical use, and don’t reflect the reality of established, unpublished, but empirical and efficacious data from the last 6 years of veterinary use of CBD. This class will present established strategies from research in medical cannabis that speak to a practical approach to dosages, and routes of administration. In the absence of FDA-CVM regulation of veterinary use of cannabis the marketplace has proliferated with numerous products, some with integrity, and others, not so much. This class will provide a logical path to the selection of a safe and effective product for use in clinics where the local state veterinary medical boards allow. Understanding how to read a third party analysis of a cannabis product is vital to being able to curate that perfect product for your clinic, and this class with dive deep into that information. Cannabis products can come from the internet, local CBD outlets or from dispensaries or provincial stores (Canada), and product format can vary widely and have an influence on palatability and absorption. This class will explain the types of product formats available and safe for veterinary use, as well as those products that may be risky, based on published studies and analyses of these products. Some product formats claim improved absorption and efficacy over other product formats. Some product formats are only available in dispensaries and may not be safe for our veterinary species. Come learn how to find that perfect product for your needs. Learning Objectives: • Learn how to read a third party certificate of analysis for product selection; • Learn about different product formats and their advantages and disadvantages; learn whether water soluble products really are better than oil tinctures, whether soft chews are less bioavailable than the water and oil soluble liquids; • Learn about “Ratio” products which contain
to know about this disease, when, why and how to test (NOT just breeding dogs), and what the options are for infected animals. Don’t put yourself, your staff, clients, or patients at risk-know what to do to diagnose and handle such patients. Real life cases will be discussed. PROSTATIC DISEASE IN THE DOG – NOT JUST FOR INTACT MALES! Joni Freshman, DVM, MS, DACVIM (SAIM), CVA, CVCP 7:00 PM - 7:50 PM | Room 200 Intact male dogs over the age of 5 essentially all have some form of prostatic disease. These include bacterial prostatitis, benign prostatic hypertrophy/hyperplasia, prostatic and paraprostatic cysts. Conditions which can affect BOTH intact and neutered dogs include prostatic neoplasia, squamous metaplasia, and chronic bacteria prostatitis. Often these diseases are silent until significant pathology is present. You can easily add monitoring to your practice for both neutered and intact dogs and know the options for diagnosis and treatment as demonstrated by cases. VAGINAL CYTOLOGY IN THE BITCH AND QUEEN: WHY AND HOW? (NOT JUST FOR INTACT FEMALES) Joni Freshman, DVM, MS, DACVIM (SAIM), CVA, CVCP 8:00 PM - 8:50 PM | Room 200 There’s a lot to vaginal cytology beyond its use in ovulation timing. When we work up a patient with vulvar discharge, getting vaginal cytology from the right location in the tract is vital to a correct diagnosis! You can also read your own if you choose to do so, adding value to your exam and practice. Is this vaginitis? Could there be an ovarian remnant? Why is this cat yowling? Why is this bitch attracting males? Cases will be used to illustrate the diversity of use of vaginal cytology. DIAGNOSIS AND TREATMENT OF DISTAL LIMB INJURIES AND LESIONS Diagnosis and treatment of a variety of injuries and other issues of the digits, metacarpals/metatarsals, carpal and tarsal bones, and carpi and tarsi will be covered. ORTHOPEDIC SURGERY: WHAT COULD GO WRONG?!! This session will be a case-based presentation of common mistakes and other complications related to a variety of orthopedic procedures regularly performed in veterinary medicine. RADIOGRAPHIC INTERPRETATION OF BONE LESIONS FROM A SURGEON’S PERSPECTIVE John Mauterer, DVM, Dip. ACVS 6:00 PM - 6:50 PM | Ballroom B John Mauterer, DVM, Dip. ACVS 7:00 PM - 7:50 PM | Ballroom B Radiographic interpretation based on private practice experience over 30 years. The tips and tricks of early and proper diagnosis of bone pathology will be discussed through a case-based presentation. INTEGRATIVE MEDICINE THURSDAY, SEPTEMBER 22 VETERINARY CANNABIS THERAPEUTICS: UNDERSTANDING THE THERAPEUTIC FRACTIONS OF THE CANNABIS SATIVA L. PLANT. Robert Silver, DVM, MS, CVA 6:00 PM - 6:50 PM | Room 204 A The story of veterinary cannabis begins with an understanding of the molecules manufactured by the plant that have clinical potency in veterinary species. Each molecular fraction of the plant is described in this class and the phyto-pharmacology of each fraction will be explained in depth and detail as relates to therapeutic potential in dogs, cats and horses, as determined by published research in veterinary, laboratory and human species. Specifically, the acidic and neutral cannabinoids, terpenes and terpenoids, and flavonoids are covered in this first class of this three part intensive on veterinary medical cannabis. Learning Objectives: • Understand the three molecular fractions derived from the Cannabis plant found to have potential and studied veterinary bioactivity; • Gain in-depth knowledge of CBD, CBDA, CBG, CBN and THC as relates to use in dogs, cats and horses; • Review safety and pharmacokinetic studies in dogs, cats and John Mauterer, DVM, Dip. ACVS 8:00 PM - 8:50 PM | Ballroom B
41
Made with FlippingBook Online newsletter maker